The stock's rise snapped a four-day losing streak.

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

On Wednesday, Hologic Inc (HOLX) stock saw a decline, ending the day at $68.75 which represents a decrease of $-1.45 or -2.07% from the prior close of $70.2. The stock opened at $69.97 and touched a ...

Day 5 of the Australian Open had it all as players battled for a place in the third round. Australian Open: Scores | Schedule | Draws Ons Jabeur taking on Camila Osorio was a match-up for connoisseurs ...

In a report released today, Michael Matson from Needham maintained a Hold rating on Masimo (MASI – Research Report). The company’s shares ...

Naomi Osaka's revenge tour continues at the Australian Open, where she bested Karolina Muchova to advance to the third round ...

Enough evidence for jury to consider failure to warn claim Case is one of nearly two dozen Hologic faces over BioZorb Hologic Inc. can’t shake a woman’s suit alleging the medical device manufacturer ...

At the heart of this transformation are the manufacturers of directed energy-based surgical systems, who are leading the way ...